ASN-FDA Collaboration Takes on Rare Kidney Disease

Patients, Industry, and Clinicians Work to Find Surrogate Endpoints for Hyperoxaluria Clinical Trials

Bridget M. Kuehn
Search for other papers by Bridget M. Kuehn in
Current site
Google Scholar
PubMed
Close
Restricted access
Save